SEC Filing Summary: MedaSorb Technologies Corporation
Business Context and Reporting Period
This Form 8-K Current Report was filed by MedaSorb Technologies Corporation (not Cytosorbents Corp) on April 28, 2008, covering the event date of April 25, 2008. The registrant is incorporated in Nevada with its principal executive office in Monmouth Junction, New Jersey.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance changes and does not contain financial statements.
Material Changes
On April 25, 2008, Martin F. Whalen resigned his position as a member of the Board of Directors of MedaSorb Technologies Corporation. No other material changes to operations or financial status are reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the disclosure of the director's departure.
Key Facts for Investor Verification
- Verify the reason for Martin F. Whalen's resignation from the Board of Directors.
- Confirm whether a replacement director has been appointed or if the board is currently understaffed.
- Note that the company name in the filing is MedaSorb Technologies Corporation, distinct from the query input of Cytosorbents Corp.
- Check subsequent filings for any financial updates, as this 8-K contains no financial data.